MedTrace Logo

Tracking Physical Activity Throughout Chemotherapy for Breast Cancer

NCT03041545 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2018-06-12

No results posted yet for this study

Summary

Physical activity during chemotherapy has been shown to increase patient health and wellbeing as well as improve outcomes in breast cancer patients. The primary aim of this project is to determine the feasibility of incorporating wearable sensors into clinical care by having breast cancer patients, undergoing chemotherapy, wear a commercially available monitor (Fitbit) that tracks physical activity, sleep, and heart rate monitor.

Conditions

Interventions

DEVICE

Fitbit

Women enrolled in the study will be asked to wear a Fitbit from one week prior to chemotherapy until six months post-chemotherapy. The Fitbit is a watch-sized, wrist worn, physical activity tracker. A button, when pressed, displays the wearer's accumulated daily steps, mileage, and steps climbed.

Sponsors & Collaborators

Principal Investigators

  • Sheri J Hartman, PhD · Assistant Professor

Eligibility

Min Age
21 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-01
Primary Completion
2018-02-08
Completion
2018-02-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03041545 on ClinicalTrials.gov